BRAIN Biotech launches MetXtra™
Published
22 August 2024
BRAIN Biotech proudly announce the launch of MetXtra™ employing cutting edge technologies to unlock the secrets of the unexplored sequence space. MetXtra™ combines the very best in enzyme discovery technologies with over 30 years of knowledge and expertise from our dedicated research and development team in Zwingenberg, Germany.
Learn more below and in the full press article on how MetXtra™ and it's three major modules, MetXtra™ database, MetXtra™ design and MetXtra™ discover support in delivering tailored enzymes using advanced bioinformatics and AI-guided enzyme selection, as well as curating tailored enzyme panels produced and delivered ready-to-screen for evaluation.
How MetXtra™ delivers optimised enzymes:
- Novelty & Innovation: Utilises a proprietary metagenomic database containing 99.8% novel sequences, not found in public databases combined with AI-driven enzyme design to foster innovation
- Expertise & Technology: Leverages sophisticated bioinformatics and AI pipelines to filter and select the most promising enzyme candidates, maximising success.
- Comprehensive Capabilities: Offers diverse expression strains, multi-parameter enzyme evaluation, analytics, and future proofs for scale-up to ensure a fast and reliable path from discovery to full commercial scale production.
